ICAAC 2013 is designed to meet the needs of health care professionals, particularly physicians, clinical microbiologists, researchers, and pharmacists, specializing in infectious diseases. Current trends will be covered regarding:
- Antimicrobial Resistance
- Clinical Trials
- Community-Acquired Infections
- Epidemiology Pharmacology
- HIV/AIDS and other Retroviruses
- Laboratory Diagnostics
- Microbial Pathogenesis
- Nosocomial Infections
- Susceptibility Studies
- Travel Medicine
- Vaccines and Immunology
ICAAC 2013 scientific program offers an educational forum which:
- Disseminates new data from research of basic microbiological sciences related to human disease;
- Updates medical professionals on clinical diagnoses, preventative modalities and therapeutics;
- Investigates the pathogenesis and epidemiology of old and new microbes;
- Evaluates the spread of infectious diseases throughout the world;
- Analyzes the developing resistance of pathogens to divers therapeutics;
- Introduces new antimicrobial agents; and
- Considers the most recent trends in healthcare management.
The primary purpose of the sessions at ICAAC 2013 is education. Information presented, as well as publications, technologies, products, and/or services discussed, are intended to inform you about the knowledge, techniques, and experiences of professionals who are willing to share such information with colleagues. A diversity of professional opinions exists in the fields discussed at ICAAC and the views of the ICAAC faculty are offered solely for educational purposes. Faculty's views neither represent those of ASM nor constitute endorsement by the association. The ASM disclaims any and all liabilities for damages to any individual attending ICAAC and for all claims which may result from the use of this information, publications, technologies, products, and/or services at ICAAC.
The France Foundation adheres to ACCME Essential Areas, Standards, and Policies regarding industry support of continuing medical education. Disclosure of the planning committee, content reviewers, and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.